Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action

Published:2016-02-08 Issue:3 Volume:8 Page:454-467
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Geoghegan James C.,Diedrich Gundo,Lu Xiaojun,Rosenthal Kim,Sachsenmeier Kris F.,Wu Herren,Dall'Acqua William F.,Damschroder Melissa M.

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/19420862.2016.1143182

Reference56 articles.

1. 5′-Nucleotidase: molecular structure and functional aspects

2. Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?

3. Tumor-promoting functions of adenosine

4. Synergy between the ectoenzymes CD39 and CD73 contributes to adenosinergic immunosuppression in human malignant gliomas

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Adenosinergic Pathway in Non-Small Cell Lung Cancer;Cancers;2024-09-13

2. NSGO-OV-UMB1/ENGOT-OV30: A phase II study of durvalumab in combination with the anti-CD73 monoclonal antibody Oleclumab in patients with relapsed ovarian cancer;Gynecologic Oncology;2024-09

3. The role of CD73 in predicting the response to immunotherapy in head and neck cancer patients;Pathology - Research and Practice;2024-08

4. COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer;British Journal of Cancer;2024-07-25

5. Mechanism-Driven Design of Multispecific Antibodies for Targeted Disease Treatment;Annual Review of Chemical and Biomolecular Engineering;2024-07-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3